Abstract

Platelets have long been known to play important roles beyond hemostasis and thrombosis. Now recognized as a bona fide mediator of malignant disease, platelets influence various aspects of cancer progression, most notably tumor cell metastasis. Interestingly, platelets isolated from cancer patients often display distinct RNA and protein profiles, with no clear alterations in hemostatic activity. This phenotypically distinct population, termed tumor-educated platelets, now receive significant attention for their potential use as a readily available liquid biopsy for early cancer detection. Although the mechanisms underpinning platelet education are still being defined, direct uptake and storage of tumor-derived factors, signal-dependent changes in platelet RNA processing, and differential platelet production by tumor-educated megakaryocytes are the most prominent scenarios. This article aims to cover the various modalities of platelet education by tumors, in addition to assessing their diagnostic potential.

REFERENCES

1.
Lefrançais
E
,
Ortiz-Muñoz
G
,
Caudrillier
A
, et al
.
The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors
.
Nature
.
2017
;
544
(
7648
):
105
-
109
.
2.
Bye
AP
,
Unsworth
AJ
,
Gibbins
JM
.
Platelet signaling: a complex interplay between inhibitory and activatory networks
.
J Thromb Haemost
.
2016
;
14
(
5
):
918
-
930
.
3.
Xu
XR
,
Zhang
D
,
Oswald
BE
, et al
.
Platelets are versatile cells: new discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond
.
Crit Rev Clin Lab Sci
.
2016
;
53
(
6
):
409
-
430
.
4.
Ferreiro
JL
,
Gómez-Hospital
JA
,
Angiolillo
DJ
.
Platelet abnormalities in diabetes mellitus
.
Diab Vasc Dis Res
.
2010
;
7
(
4
):
251
-
259
.
5.
Franco
AT
,
Corken
A
,
Ware
J
.
Platelets at the interface of thrombosis, inflammation, and cancer
.
Blood
.
2015
;
126
(
5
):
582
-
588
.
6.
Bouillaud
S
,
Bouillaud
J
.
De l’obliteration des veines et de son influence sur la formation des hydropisies partielles: consideration sur la hydropisies passive et general
.
Arch Gen Med
.
1823
;
1
:
188
-
204
.
7.
Trousseau
A
.
Clinique Médicale de L’HôtelDieu de Paris
. 2nd ed.
Paris, France
:
J.-B. Baillière et Fils
;
1865
.
8.
Bizzozero
J
.
Ueber einen neuen formbestandtheil des blutes und dessen rolle bei der thrombose und der blutgerinnung
.
Virchows Arch Pathol Anat Physiol Klin Med
.
1882
;
90
(
2
):
261
-
332
.
9.
Levin
J
,
Conley
CL
.
Thrombocytosis associated with malignant disease
.
Arch Intern Med
.
1964
;
114
(
4
):
497
-
500
.
10.
Bailey
SE
,
Ukoumunne
OC
,
Shephard
EA
,
Hamilton
W
.
Clinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data
.
Br J Gen Pract
.
2017
;
67
(
659
):
e405
-
e413
.
11.
Gasic
GJ
,
Gasic
TB
,
Galanti
N
,
Johnson
T
,
Murphy
S
.
Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease
.
Int J Cancer
.
1973
;
11
(
3
):
704
-
718
.
12.
Gasic
GJ
,
Gasic
TB
,
Stewart
CC
.
Antimetastatic effects associated with platelet reduction
.
Proc Natl Acad Sci USA
.
1968
;
61
(
1
):
46
-
52
.
13.
Camerer
E
,
Qazi
AA
,
Duong
DN
,
Cornelissen
I
,
Advincula
R
,
Coughlin
SR
.
Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis
.
Blood
.
2004
;
104
(
2
):
397
-
401
.
14.
Shirai
T
,
Revenko
AS
,
Tibbitts
J
, et al
.
Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice
.
Blood Adv
.
2019
;
3
(
20
):
3080
-
3091
.
15.
Labelle
M
,
Begum
S
,
Hynes
RO
.
Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis
.
Cancer Cell
.
2011
;
20
(
5
):
576
-
590
.
16.
Labelle
M
,
Begum
S
,
Hynes
RO
.
Platelets guide the formation of early metastatic niches
.
Proc Natl Acad Sci USA
.
2014
;
111
(
30
):
E3053
-
E3061
.
17.
Schlesinger
M
.
Role of platelets and platelet receptors in cancer metastasis
.
J Hematol Oncol
.
2018
;
11
(
1
):
125
.
18.
Gay
LJ
,
Felding-Habermann
B
.
Contribution of platelets to tumour metastasis
.
Nat Rev Cancer
.
2011
;
11
(
2
):
123
-
134
.
19.
Xu
XR
,
Yousef
GM
,
Ni
H
.
Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents
.
Blood
.
2018
;
131
(
16
):
1777
-
1789
.
20.
Pollard
JW
.
Tumour-educated macrophages promote tumour progression and metastasis
.
Nat Rev Cancer
.
2004
;
4
(
1
):
71
-
78
.
21.
Battinelli
EM
,
Markens
BA
,
Italiano
JE
Jr.
Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis
.
Blood
.
2011
;
118
(
5
):
1359
-
1369
.
22.
Maynard
DM
,
Heijnen
HF
,
Horne
MK
,
White
JG
,
Gahl
WA
.
Proteomic analysis of platelet alpha-granules using mass spectrometry
.
J Thromb Haemost
.
2007
;
5
(
9
):
1945
-
1955
.
23.
Davizon-Castillo
P
,
McMahon
B
,
Aguila
S
, et al
.
TNF-α-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging
.
Blood
.
2019
;
134
(
9
):
727
-
740
.
24.
Leblanc
R
,
Peyruchaud
O
.
Metastasis: new functional implications of platelets and megakaryocytes
.
Blood
.
2016
;
128
(
1
):
24
-
31
.
25.
Middleton
EA
,
Rowley
JW
,
Campbell
RA
, et al
.
Sepsis alters the transcriptional and translational landscape of human and murine platelets
.
Blood
.
2019
;
134
(
12
):
911
-
923
.
26.
Best
MG
,
Sol
N
,
In ’t Veld
SGJG
, et al
.
Swarm intelligence-enhanced detection of non-small-cell lung cancer using tumor-educated platelets
.
Cancer Cell
.
2017
;
32
(
2
):
238
-
252.e9
.
27.
Kuznetsov
HS
,
Marsh
T
,
Markens
BA
, et al
.
Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells
.
Cancer Discov
.
2012
;
2
(
12
):
1150
-
1165
.
28.
Ni
H
,
Papalia
JM
,
Degen
JL
,
Wagner
DD
.
Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain
.
Blood
.
2003
;
102
(
10
):
3609
-
3614
.
29.
Klement
GL
,
Yip
TT
,
Cassiola
F
, et al
.
Platelets actively sequester angiogenesis regulators
.
Blood
.
2009
;
113
(
12
):
2835
-
2842
.
30.
Peterson
JE
,
Zurakowski
D
,
Italiano
JE
Jr
, et al
.
VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients
.
Angiogenesis
.
2012
;
15
(
2
):
265
-
273
.
31.
Salgado
R
,
Benoy
I
,
Bogers
J
, et al
.
Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study
.
Angiogenesis
.
2001
;
4
(
1
):
37
-
43
.
32.
Banerjee
M
,
Whiteheart
SW
.
The ins and outs of endocytic trafficking in platelet functions
.
Curr Opin Hematol
.
2017
;
24
(
5
):
467
-
474
.
33.
Banerjee
M
,
Joshi
S
,
Zhang
J
, et al
.
Cellubrevin/vesicle-associated membrane protein-3-mediated endocytosis and trafficking regulate platelet functions
.
Blood
.
2017
;
130
(
26
):
2872
-
2883
.
34.
Kerr
BA
,
McCabe
NP
,
Feng
W
,
Byzova
TV
.
Platelets govern pre-metastatic tumor communication to bone
.
Oncogene
.
2013
;
32
(
36
):
4319
-
4324
.
35.
Nilsson
RJ
,
Balaj
L
,
Hulleman
E
, et al
.
Blood platelets contain tumor-derived RNA biomarkers
.
Blood
.
2011
;
118
(
13
):
3680
-
3683
.
36.
Nilsson
RJ
,
Karachaliou
N
,
Berenguer
J
, et al
.
Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer
.
Oncotarget
.
2016
;
7
(
1
):
1066
-
1075
.
37.
Park
CK
,
Kim
JE
,
Kim
MS
, et al
.
Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer
.
J Cancer Res Clin Oncol
.
2019
;
145
(
8
):
2071
-
2082
.
38.
Luo
CL
,
Xu
ZG
,
Chen
H
, et al
.
LncRNAs and EGFRvIII sequestered in TEPs enable blood-based NSCLC diagnosis
.
Cancer Manag Res
.
2018
;
10
:
1449
-
1459
.
39.
Warshaw
AL
,
Laster
L
,
Shulman
NR
.
Protein synthesis by human platelets
.
J Biol Chem
.
1967
;
242
(
9
):
2094
-
2097
.
40.
Alhasan
AA
,
Izuogu
OG
,
Al-Balool
HH
, et al
.
Circular RNA enrichment in platelets is a signature of transcriptome degradation
.
Blood
.
2016
;
127
(
9
):
e1
-
e11
.
41.
Teruel-Montoya
R
,
Kong
X
,
Abraham
S
, et al
.
MicroRNA expression differences in human hematopoietic cell lineages enable regulated transgene expression
.
PLoS One
.
2014
;
9
(
7
):
e102259
.
42.
Denis
MM
,
Tolley
ND
,
Bunting
M
, et al
.
Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets
.
Cell
.
2005
;
122
(
3
):
379
-
391
.
43.
Gnatenko
DV
,
Dunn
JJ
,
McCorkle
SR
,
Weissmann
D
,
Perrotta
PL
,
Bahou
WF
.
Transcript profiling of human platelets using microarray and serial analysis of gene expression
.
Blood
.
2003
;
101
(
6
):
2285
-
2293
.
44.
Nagalla
S
,
Shaw
C
,
Kong
X
, et al
.
Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity
.
Blood
.
2011
;
117
(
19
):
5189
-
5197
.
45.
Schubert
S
,
Weyrich
AS
,
Rowley
JW
.
A tour through the transcriptional landscape of platelets
.
Blood
.
2014
;
124
(
4
):
493
-
502
.
46.
Schwertz
H
,
Tolley
ND
,
Foulks
JM
, et al
.
Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets
.
J Exp Med
.
2006
;
203
(
11
):
2433
-
2440
.
47.
Weyrich
AS
,
Dixon
DA
,
Pabla
R
, et al
.
Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets
.
Proc Natl Acad Sci USA
.
1998
;
95
(
10
):
5556
-
5561
.
48.
Rondina
MT
,
Schwertz
H
,
Harris
ES
, et al
.
The septic milieu triggers expression of spliced tissue factor mRNA in human platelets
.
J Thromb Haemost
.
2011
;
9
(
4
):
748
-
758
.
49.
Kim
YJ
,
Borsig
L
,
Varki
NM
,
Varki
A
.
P-selectin deficiency attenuates tumor growth and metastasis
.
Proc Natl Acad Sci USA
.
1998
;
95
(
16
):
9325
-
9330
.
50.
Yang
H
,
Lang
S
,
Zhai
Z
, et al
.
Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression
.
Blood
.
2009
;
114
(
2
):
425
-
436
.
51.
Plé
H
,
Maltais
M
,
Corduan
A
,
Rousseau
G
,
Madore
F
,
Provost
P
.
Alteration of the platelet transcriptome in chronic kidney disease
.
Thromb Haemost
.
2012
;
108
(
4
):
605
-
615
.
52.
Lood
C
,
Amisten
S
,
Gullstrand
B
, et al
.
Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease
.
Blood
.
2010
;
116
(
11
):
1951
-
1957
.
53.
Calverley
DC
,
Phang
TL
,
Choudhury
QG
, et al
.
Significant downregulation of platelet gene expression in metastatic lung cancer
.
Clin Transl Sci
.
2010
;
3
(
5
):
227
-
232
.
54.
Takagi
S
,
Tsukamoto
S
,
Park
J
, et al
.
Platelets enhance multiple myeloma progression via IL-1β upregulation
.
Clin Cancer Res
.
2018
;
24
(
10
):
2430
-
2439
.
55.
Spizzo
R
,
Almeida
MI
,
Colombatti
A
,
Calin
GA
.
Long non-coding RNAs and cancer: a new frontier of translational research?
Oncogene
.
2012
;
31
(
43
):
4577
-
4587
.
56.
Wang
H
,
Wei
X
,
Wu
B
,
Su
J
,
Tan
W
,
Yang
K
.
Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis
.
Cancer Manag Res
.
2019
;
11
:
3351
-
3360
.
57.
Suzuki
A
,
Takahashi
T
,
Nakamura
K
, et al
.
Thrombocytosis in patients with tumors producing colony-stimulating factor
.
Blood
.
1992
;
80
(
8
):
2052
-
2059
.
58.
Stone
RL
,
Nick
AM
,
McNeish
IA
, et al
.
Paraneoplastic thrombocytosis in ovarian cancer [published correction appears in N Engl J Med. 2012;367(18):1768]
.
N Engl J Med
.
2012
;
366
(
7
):
610
-
618
.
59.
Zaslavsky
A
,
Baek
KH
,
Lynch
RC
, et al
.
Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis
.
Blood
.
2010
;
115
(
22
):
4605
-
4613
.
60.
Schulze
H
,
Stegner
D
.
Imaging platelet biogenesis in vivo
.
Res Pract Thromb Haemost
.
2018
;
2
(
3
):
461
-
468
.
61.
Cecchetti
L
,
Tolley
ND
,
Michetti
N
,
Bury
L
,
Weyrich
AS
,
Gresele
P
.
Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events
.
Blood
.
2011
;
118
(
7
):
1903
-
1911
.
62.
Gerlinger
M
,
Rowan
AJ
,
Horswell
S
, et al
.
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
.
N Engl J Med
.
2012
;
366
(
10
):
883
-
892
.
63.
Vaidyanathan
R
,
Soon
RH
,
Zhang
P
,
Jiang
K
,
Lim
CT
.
Cancer diagnosis: from tumor to liquid biopsy and beyond
.
Lab Chip
.
2018
;
19
(
1
):
11
-
34
.
64.
De Rubis
G
,
Rajeev Krishnan
S
,
Bebawy
M
.
Liquid biopsies in cancer diagnosis, monitoring, and prognosis
.
Trends Pharmacol Sci
.
2019
;
40
(
3
):
172
-
186
.
65.
Cazenave
JP
,
Ohlmann
P
,
Cassel
D
,
Eckly
A
,
Hechler
B
,
Gachet
C
.
Preparation of washed platelet suspensions from human and rodent blood
.
Methods Mol Biol
.
2004
;
272
:
13
-
28
.
66.
Bailey
SE
,
Ukoumunne
OC
,
Shephard
E
,
Hamilton
W
.
How useful is thrombocytosis in predicting an underlying cancer in primary care? A systematic review
.
Fam Pract
.
2017
;
34
(
1
):
4
-
10
.
67.
Asher
V
,
Lee
J
,
Innamaa
A
,
Bali
A
.
Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
.
Clin Transl Oncol
.
2011
;
13
(
7
):
499
-
503
.
68.
Sabrkhany
S
,
Kuijpers
MJE
,
van Kuijk
SMJ
, et al
.
A combination of platelet features allows detection of early-stage cancer
.
Eur J Cancer
.
2017
;
80
:
5
-
13
.
69.
Gasparyan
AY
,
Ayvazyan
L
,
Mikhailidis
DP
,
Kitas
GD
.
Mean platelet volume: a link between thrombosis and inflammation?
Curr Pharm Des
.
2011
;
17
(
1
):
47
-
58
.
70.
Lomnytska
M
,
Pinto
R
,
Becker
S
, et al
.
Platelet protein biomarker panel for ovarian cancer diagnosis
.
Biomark Res
.
2018
;
6
:
2
.
71.
Sabrkhany
S
,
Kuijpers
MJE
,
Knol
JC
, et al
.
Exploration of the platelet proteome in patients with early-stage cancer
.
J Proteomics
.
2018
;
177
:
65
-
74
.
72.
Raghavachari
N
,
Xu
X
,
Harris
A
, et al
.
Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease
.
Circulation
.
2007
;
115
(
12
):
1551
-
1562
.
73.
Freedman
JE
,
Larson
MG
,
Tanriverdi
K
, et al
.
Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study
.
Circulation
.
2010
;
122
(
2
):
119
-
129
.
74.
Eicher
JD
,
Wakabayashi
Y
,
Vitseva
O
, et al
.
Characterization of the platelet transcriptome by RNA sequencing in patients with acute myocardial infarction
.
Platelets
.
2016
;
27
(
3
):
230
-
239
.
75.
Best
MG
,
Sol
N
,
Kooi
I
, et al
.
RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics
.
Cancer Cell
.
2015
;
28
(
5
):
666
-
676
.
76.
Brinkman
K
,
Meyer
L
,
Bickel
A
, et al
.
Extracellular vesicles from plasma have higher tumour RNA fraction than platelets
.
J Extracell Vesicles
.
2020
;
9
(
1
):
1741176
.
77.
Huang
G
,
Yuan
M
,
Chen
M
, et al
.
Integrating multiple fitting regression and Bayes decision for cancer diagnosis with transcriptomic data from tumor-educated blood platelets
.
Analyst (Lond)
.
2017
;
142
(
19
):
3588
-
3597
.
78.
Heinhuis
KM
,
In ’t Veld
SGJG
,
Dwarshuis
G
, et al
.
RNA-sequencing of tumor-educated platelets, a novel biomarker for blood-based sarcoma diagnostics
.
Cancers (Basel)
.
2020
;
12
(
6
):
1372
.
79.
Sheng
M
,
Dong
Z
,
Xie
Y
.
Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer
.
OncoTargets Ther
.
2018
;
11
:
8143
-
8151
.
80.
Best
MG
,
In ’t Veld
SGJG
,
Sol
N
,
Wurdinger
T
.
RNA sequencing and swarm intelligence-enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA
.
Nat Protoc
.
2019
;
14
(
4
):
1206
-
1234
.
81.
Lasham
A
,
Fitzgerald
SJ
,
Knowlton
N
, et al
.
A predictor of early disease recurrence in patients with breast cancer using a cell-free RNA and protein liquid biopsy
.
Clin Breast Cancer
.
2020
;
20
(
2
):
108
-
116
.
82.
Olmedillas-López
S
,
García-Arranz
M
,
García-Olmo
D
.
Current and emerging applications of droplet digital PCR in oncology
.
Mol Diagn Ther
.
2017
;
21
(
5
):
493
-
510
.
83.
Psaila
B
,
Wang
G
,
Rodriguez-Meira
A
, et al;
NIH Intramural Sequencing Center
.
Single-cell analyses reveal megakaryocyte-biased hematopoiesis in myelofibrosis and identify mutant clone-specific targets
.
Mol Cell
.
2020
;
78
(
3
):
477
-
492.e8
.
84.
Zhang
X
,
Wang
J
,
Chen
Z
, et al
.
Engineering PD-1-presenting platelets for cancer immunotherapy
.
Nano Lett
.
2018
;
18
(
9
):
5716
-
5725
.
85.
Wang
C
,
Sun
W
,
Ye
Y
,
Hu
Q
,
Bomba
HN
,
Gu
Z
.
In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
.
Nat Biomed Eng
.
2017
;
1
(
2
):
1
-
10
.
86.
Papa
A-L
,
Jiang
A
,
Korin
N
, et al
.
Platelet decoys inhibit thrombosis and prevent metastatic tumor formation in preclinical models
.
Sci Transl Med
.
2019
;
11
(
479
):
eaau5898
.
You do not currently have access to this content.

Sign in via your Institution

Sign In